BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8496874)

  • 1. Methotrexate therapy in childhood systemic lupus erythematosus.
    Abud-Mendoza C; Sturbaum AK; Vazquez-Compean R; Gonzalez-Amaro R
    J Rheumatol; 1993 Apr; 20(4):731-3. PubMed ID: 8496874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A; Ballardini G; Viola S; Villa I; Ruperto N; Martini A
    J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR; Sato EI
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2 year, open ended trial of methotrexate in systemic lupus erythematosus.
    Wilson K; Abeles M
    J Rheumatol; 1994 Sep; 21(9):1674-7. PubMed ID: 7799348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate in systemic lupus erythematosus.
    Walz LeBlanc BA; Dagenais P; Urowitz MB; Gladman DD
    J Rheumatol; 1994 May; 21(5):836-8. PubMed ID: 8064722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of the treatment of systemic lupus erythematosus with methotrexate].
    Guil García M; García Portales R; Fernández Nebro A; Belmonte López MA; Camps García MT; de Ramón Garrido E
    Med Clin (Barc); 1993 Oct; 101(10):361-4. PubMed ID: 8231340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate in nonrenal lupus and undifferentiated connective tissue disease--a review of 36 patients.
    Wise CM; Vuyyuru S; Roberts WN
    J Rheumatol; 1996 Jun; 23(6):1005-10. PubMed ID: 8782131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.
    Sarkissian T; Beyene J; Feldman B; McCrindle B; Silverman ED
    Arthritis Rheum; 2007 Feb; 56(2):631-8. PubMed ID: 17265498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
    Stone JH; Tun W; Hellman DB
    J Rheumatol; 1999 May; 26(5):1134-9. PubMed ID: 10332980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bowel perforation and interstitial cystitis in childhood systemic lupus erythematosus.
    Eberhard A; Shore A; Silverman E; Laxer R
    J Rheumatol; 1991 May; 18(5):746-7. PubMed ID: 1865424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous cyclophosphamide therapy of severe SLE.
    McCune WJ; Fox D
    Rheum Dis Clin North Am; 1989 Aug; 15(3):455-77. PubMed ID: 2672132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Fortin PR; Abrahamowicz M; Ferland D; Lacaille D; Smith CD; Zummer M;
    Arthritis Rheum; 2008 Dec; 59(12):1796-804. PubMed ID: 19035431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient monthly oral bolus cyclophosphamide therapy in systemic lupus erythematosus.
    Dawisha SM; Yarboro CH; Vaughan EM; Austin HA; Balow JE; Klippel JH
    J Rheumatol; 1996 Feb; 23(2):273-8. PubMed ID: 8882031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive therapy of systemic lupus erythematosus].
    Miescher PA; Lambert PH
    Ther Umsch; 1971 Sep; 28(9):579-85. PubMed ID: 5122520
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA; McCune WJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus.
    Marks SD; Patey S; Brogan PA; Hasson N; Pilkington C; Woo P; Tullus K
    Arthritis Rheum; 2005 Oct; 52(10):3168-74. PubMed ID: 16200620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
    Rahman P; Humphrey-Murto S; Gladman DD; Urowitz MB
    J Rheumatol; 1998 Feb; 25(2):243-6. PubMed ID: 9489814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influential factors of systemic lupus erythematosus activity during pregnancy and its relationship with pregnancy outcome].
    Wang YH; Wu XX; Tan JP; Zhang JP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):601-4. PubMed ID: 17181969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate therapy in systemic lupus erythematosus.
    Sato EI
    Lupus; 2001; 10(3):162-4. PubMed ID: 11315346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.